Invited Speakers

Prof. Dr. Ale Algra

University Medical Center Utrecht, The Netherlands

JUNE 27, 2019 08:30 - 10:15
Risk factors for and time trends in the worldwide incidence of aneurysmal subarachnoid hemorrhage


view bio

Prof. Dr. Sepideh Amin-Hanjani

University of Illinois, USA

JUNE 26, 2019 16:30 - 18:00
Advances/challenges in aneurysm repair (a neurosurgical perspective)


view bio

Prof. Dr. Tomohiro Aoki

Kyoto University, Japan

JUNE 26, 2019 11:00 - 12:45
Molecular basis for aneurysm wall formation, growth and rupture.


view bio

Associate Professor Alex H. Choi

University of Texas, USA

JUNE 26, 2019  08:45 - 10:30
Role of inflammation in early brain injury after SAH

Associate Professor Sherry Hsiang-Yi Chou

University of Pittsburgh, USA

JUNE 26, 2019 16:30 - 18:00
Established and promising biomarkers in SAH


view bio

Associate Professor Jan Claassen

Columbia University, USA

JUNE 28, 2019 08:30 - 10:30
Electrophysiological monitoring after aneurysmal SAH


view bio

Prof. Dr. Michael Diringer

Washington University, USA

JUNE 27, 2019 14:00 - 15:45
Subarachnoid hemorrhage is a multisystem disease


view bio

Prof. Dr. Jens Dreier

Charité University Berlin, Germany

JUNE 26, 2019 14:15 - 16:00
20 years of research on cortical spreading depolarizations: answered and unanswered questions


view bio

Assistant Professor Shane English

The Ottawa Hospital, Canada

JUNE 27, 2019  10:45 - 12:30
Aneurysmal subarachnoid hemorrhage - red blood cell transfusion and outcome (SAHaRA): a randomized controlled trial (rationale and study status).


view bio

Prof. Dr. Nima Etminan

Medical Faculty Mannheim, University of Heidelberg, Germany

JUNE 27, 2019  10:45 - 12:30
PROTECT-U (rationale and study status)


view bio

Assistant Professor Thomas Gaberel

University Hospital of Caen, France

JUNE 27, 2019  10:45 - 12:30
French Intraventricular fibrinolysis trial (rationale and study status)


view bio

Prof. Dr. Daniel Hänggi

University of Heidelberg, Germany, Medical Faculty Mannheim

JUNE 27, 2019  10:45 - 12:30
Final results of the NEWTON 2 trial


view bio

Associate Professor David Hasan

University of Iowa Hospitals, USA

JUNE 27, 2019  16:15 - 18:00
Novel radiological surrogates to estimate the risk of rupture in intracranial aneurysms


view bio

Associate Professor Raimund Helbok

Medical University of Innsbruck, Austria

JUNE 27, 2019 14:00 - 15:45
Respiratory complications and management in patients with SAH


view bio

Prof. Dr. Nerissa Ko

University of California, San Francisco, USA

JUNE 27, 2019 10:45 - 12:30
Defining and monitoring neuroinflammation in SAH


view bio

Prof. Dr. Martin Lauritzen

University of Copenhagen, Denmark

JUNE 27, 2019  08:30 - 10:15
Neurovascular coupling and CBF regulation in the healthy brain


view bio

Associate Professor Hester Lingsma

Erasmus MC, The Netherlands

JUNE 28, 2019  11:00 - 12:45
Alternative study designs for studying the effect of interventions in patients with SAH – pros and cons

Prof. Dr. Robert Loch Macdonald

Edge Therapeutics, Inc. / University of Toronto, Canada

JUNE 26, 2019  08:45 - 10:30
Relationship between early brain injury and delayed cerebral ischemia


view bio

PD Dr. Med. Serge Marbacher

Kantonsspital Aarau, Switzerland

JUNE 27, 2019  08:30 - 10:15
Animal models in SAH research: towards standardization of experiments.


view bio

Prof. Dr. Stephan A. Mayer

William T. Gossett Endowed Chair of Neurology, USA

Neuropsychological outcomes in SAH patients: lessons learned and future perspectives


view bio

Prof. Dr. Akio Morita

Nippon Medical School, Japan

JUNE 26, 2019 11:00 - 12:45
Lessons learned from a ‘natural history study’ in unruptured intracranial aneurysms


view bio

Assistant Professor Sarah Nelson

Johns Hopkins Hospital, USA

JUNE 27, 2019  16:15 - 18:00
Quantifying MRI-specific features of injury in SAH


view bio

Prof. Dr. Hiroki Ohkuma

University of Hirosaki, Japan

JUNE 28, 2019 08:30 - 10:30
Microthrombosis and arteriolar constrictions after SAH


view bio

MD Hiren Patel

University of Manchester, UK

JUNE 27, 2019  10:45 - 12:30
Interleukin-1 receptor antibodies for SAH (rationale and study status)

Prof. Dr. Nikolaus Plesnila

Ludwig- Maximilians Universitat München, Germany

JUNE 27, 2019  08:30 - 10:15
Translation of animal research into novel clinical treatments


view bio

Associate Professor Javier Provencio

University of Virginia School of Medicine, USA

JUNE 28, 2019 08:30 - 10:30
Brain monitoring after SAH: lessons learned


view bio

Prof. Dr. Gabriel Rinkel

University Medical Center Utrecht, The Netherlands

JUNE 27, 2019 08:30 - 10:15
Long-term outcomes after SAH


view bio

Associate Professor Ynte Ruigrok

University Medical Center Utrecht, The Netherlands

JUNE 26, 2019 16:30 - 18:00
The International Stroke Genetics Consortium; how it will improve our knowledge on the role of genetics in patients with intracranial aneurysms


view bio

Prof. Dr. Bill Shuttleworth

University of New Mexico, USA

JUNE 28, 2019 08:30 - 10:30
Relationship between spreading depolarizations and microcirculatory disturbances after SAH


view bio

Prof. Dr. Adnan Siddiqui

State University of New York at Buffalo, USA

JUNE 26, 2019 16:30 - 18:00
Advances/challenges in aneurysm repair (a hybrid neurosurgeon’s perspective)


view bio

Prof. Dr. Jose Suarez

Johns Hopkins Hospital, USA

JUNE 28, 2019  11:00 - 12:45
ALISAH II / summary update and the future of Common Data Elements in SAH research

Prof. Dr. Hidenori Suzuki

Mie University, Japan

JUNE 27, 2019 10:45 - 12:30
Neuroinflammation as a target for intervention in subarachnoid hemorrhage


view bio

Assistant Professor Walter van den Bergh

University of Groningen, The Netherlands

JUNE 26, 2019 14:15 - 16:00
Is there a role for hypertension induction after the HIMALAIA trial?


view bio

Prof. Dr. Peter Vandertop

Amsterdam University Medical Centers , The Netherlands

JUNE 27, 2019  10:45 - 12:30
ULTRA early tranexamic acid after subarachnoid hemorrhage (rationale and study status)

Associate Professor Mervyn Vergouwen

University Medical Center Utrecht, The Netherlands

JUNE 27, 2019  10:45 - 12:30
PROTECT-U (rationale and study status)


view bio

Dr. Stefan Wolf

Charité University Berlin, Germany

JUNE 27, 2019  10:45 - 12:30
EARLY DRAIN trial (rational and study status)


view bio

Prof. Dr. Kwok Chu George Wong

Chinese University of Hong Kong, China

JUNE 27, 2019 16:15 - 18:00
Cerebral infarction and cognitive outcome after SAH


view bio

Newsletter

Sign up to be notified of news

Venue

Muziekgebouw aan 't IJ Amsterdam
Piet Heinkade 1
1019 BR Amsterdam, The Netherlands
Founded in 2005; Muziekgebouw aan 't IJ is the most important stage for contemporary music in the Netherlands. It is located above the IJtunnel, a ten-minute walk from Amsterdam Central Station. The building was designed by Danish architects 3XN. Spacious modern rooms, parking directly under the building and an unparalleled view: Muziekgebouw aan 't IJ has it all in house.

Organization Secretariat

Kenes M+

General Inquiries:
Ms. Merve Tufekci
mtufekci@kenes.com